Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-01-13 00:00:00 ET · period of report 2022-01-12 · accession 0001437749-22-000889 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-13 | 2022-01-12 | BLFS | Schulz Marcus | Chief Revenue Off | S - Sale | $32.18 | -267 | 28.8K | -0.9% | -$8,592 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-12 | S | D | 267 | $32.18 | 28,786 | D | — | — | (F1) The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |